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Though robust clinical data are available within
transplantation, these data are not used for broad-
based, multicentered quality improvement initiates.
This article describes a targeted quality improve-
ment initiative within the Studies of Pediatric Liver
Transplantation (SPLIT) Registry. Using standard sta-
tistical techniques and clinical expertise to adjust for
data and statistical reliability, we identified the pedi-
atric liver transplant centers in North America with
the lowest hepatic artery thrombosis rate and biliary
complication rates. A survey was completed to estab-
lish current practices within the entire SPLIT group.
Surgeons from the highest performing centers pre-
sented a detailed, technically oriented overview of
their current practices. The presentations and discus-
sion that followed were recorded and form the basis
of the best practices described herein. We frame this
work as a unique six-step approach roadmap that may
serve as an efficient and cost effective model for novel
broad-based quality improvement initiatives within
transplantation.
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Introduction
Few areas of medicine have more robust clinical outcomes
data than transplantation. Transplant centers are required
to report large amounts of data regarding transplant can-
didates, recipients and donors. These data are currently
used to inform policy and assure quality and have led to an
explosion of health services research in the field of clinical
transplantation. Undoubtedly, this research has improved
the management and care of transplant patients.
Despite the mass of data available, clinical transplant reg-
istries have not been leveraged for broad-based quality
improvement programs. Certainly, these data are used by
regulators and payers to measure performance, but that
is quality assurance and not quality improvement. As has
been described before, quality improvement takes much
more than just high quality data; it requires clinical ex-
pertise, a collegial and noncompetitive atmosphere, and
a comprehensive quality improvement plan (1,2). Clinician-
driven collaboratives such as the Michigan Surgical Quality
Collaborative (MSQC) the and the New England Cardiovas-
cular Disease Study Group have demonstrated significant
success with improving outcomes and accelerate improve-
ments in practice (2–8). For example, the MSQC (a collab-
orative of 52 Michigan hospitals) has resulted in a 15%
reduction in length of stay, 18% reduction in surgical site in-
fections and a 2.6% reduction in surgical complications re-
sulting in an $85 million in Statewide savings (3,9,10). Con-
sidering the robust available data, narrow case-mix, and
small clinician community, transplantation is well suited to
use these validated QI methods (1). A potential template
for such efforts involves our recent work within the Studies
for Pediatric Liver Transplantation (SPLIT) group.
SPLIT was established in 1995, and to date has a de-
tailed database of over 4000 pediatric liver transplant re-
cipients in the United States and Canada. This group has a
track record of contributing important research and policy
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Figure 1: Biliary complication rates
across North American pediatric
liver transplant centers.
initiatives in pediatric liver transplantation (11–19). Re-
cently, our group began to focus on the variation in out-
comes across transplant centers within the collaborative.
Using data from the SPLIT and Organ Procurement and
Transplantation Network (OPTN) databases, we observed
a 1-year survival that ranged from less than 50% to 100%.
Even when we considered the unreliability of measuring
performance at low-volume pediatric transplant centers,
there remained a 20% differential in 1-year survival among
transplant centers in North America. Appreciating the im-
portant limitations of analyses like these, observations
such as this one and others motivated our group to estab-
lish a Clinical Care and Quality Improvement Committee
within SPLIT.
With this manuscript, we will describe one arm of our
QI efforts within SPLIT relating to technical aspects of the
transplant operation. In this regard, our first two targets for
quality improvement were the incidence of hepatic artery
thrombosis and biliary complications. As with mortality
data, we noted a broad variation in rates of these mor-
bid complications following pediatric liver transplantation.
With help from the highest performing transplant centers;
we have developed best practices and a comprehensive
quality improvement plan. A key component of the plan
is to discuss the importance of this work as well as to
disseminate best practice guidelines, which in part is the
motivation for this manuscript. Finally, we will highlight fu-
ture quality improvement plans within this collaborative,
focusing on our goal to improve the care of children with
end-stage liver disease.
More broadly, this approach to QI is adapted from success-
ful work with clinician led QI collaboratives within Michigan
and New England (3,5–8). Motivated by these successes,
the transplant community should consider this work as
a roadmap for much needed, physician driven QI efforts
within transplantation.
Step 1: Identification of the Highest
Performing Centers
Though all efforts were made to follow rigorous methods,
selection of high-performing centers involved more than
just statistical analysis. We choose hepatic artery throm-
bosis and biliary complications because they are common,
clinically relevant, have significant variation between cen-
ters and are reliably reported within the SPLIT database.
Though specific definitions for these complications do ex-
ist, members of the committee discussed extensively the
reliability of the data reporting. Data reporting fields that
could be verified (such as transplant volume) were cross-
reference with OPTN data in an effort to assure that only
centers with a good track record of data reporting were
considered for these efforts. We chose a relatively recent
observation period (2005–2009). Members of the SPLIT QI
committee identified the highest performing centers, con-
sidering hospital rankings, data reliability and potential con-
founding clinical variables. Broad variations in outcomes
were noted (Figures 1 and 3). We first ranked transplant
centers based on their unadjusted hepatic artery thrombo-
sis and biliary complication rates (center-specific adjusted
outcomes were not feasible due to small sample size). In a
further effort to optimize the reliability of these data, low-
volume transplant centers (< 10 transplants) were elimi-
nated from consideration (20). Potential confounding vari-
ables such as rates of living donor, age of recipients, split
transplants were taken into account. However, the high-
performing centers also had high rates of living and split
transplants, even though both of these variables are well
known as risk factors for hepatic artery thrombosis and
biliary complications (21–24).
Careful consideration was taken in the process of review-
ing center-specific outcomes. First, QI committee mem-
bers were blinded to the center identification. Second,
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Figure 2: Hepatic artery thrombosis
rates across North American pediatric
liver transplant centers.
the entire focus of the committee effort was on high-
performing centers, thereby negating concerns of public
ridicule and competitive advantage among members of
low-performing centers. It is important to note that focus-
ing on low performance is not a productive QI approach, as
has clearly been established with previous work (2). Once
the de-identified highest performing centers were chosen,
a member of the data coordinating center (not a clinician)
discussed with the high-performing center whether they
would be willing to participate in these efforts and thereby
have their outcomes data identified to members of SPLIT.
Both of the high-performing centers were happy to par-
ticipate, share their expertise and have their exceptional
outcomes exemplified and celebrated.
Step 2: Survey of Best Practices
Since hepatic artery thrombosis and biliary complications
are primarily surgical issues, we surveyed surgeons within
SPLIT regarding their own practices. The hepatic artery
thrombosis survey (10 questions) involved questions of
use of anticoagulants, thoughts on specific technical con-
siderations that minimize hepatic artery thrombosis, ques-
tions regarding donor selection and questions regarding
the surgical team. The biliary complications survey (8 ques-
tions) involve questions regarding use of duct to duct anas-
tomoses, use of biliary stents, selection of suture type and
technique, and management of biliary complications. The
purpose of the survey was not to establish best practices,
but was to establish current practices and lead discussion
at the QI session at the annual SPLIT meeting. It was clear
after 90 min of discussion that there was broad variation
in current practices. Specific best practices will be high-
lighted in the following sections. The specifics of the re-
sponses to the questions are not detailed herein because
of the remarkable variation in responses, making interpre-
tation difficult. Moreover, it was clear that the complexity
of the technical approaches was best suited to discussion
and not a survey of practices.
Step 3a: Best Practice Report: Hepatic
Artery Thrombosis
Using the survey as a framework, we then asked a surgeon
from the highest performing center (lowest hepatic artery
thrombosis rate) to give a talk on best practices, specifically
focusing on the surgical technique. The program presented
the following as key components of their best practices:
1. High-volume pediatric and adult liver transplant pro-
gram with high-volume surgeons and a high-volume
living donor liver transplant program.
2. No intraoperative anticoagulation.
3. No touch technique and avoid traction injury to the
artery.
4. Hand-held Doppler verification of flow in both
postanastomotic and intrahepatic locations.
5. Split transplants:
a. Child gets the entire artery.
b. Usually anastomosed to a branch patch of the re-
cipient hepatic artery and gastroduodenal artery.
c. Leave the artery just the right length or very long.
d. 7–0 Prolene sutureswith parachuting the backwall
and interrupting the front wall.
e. Infrarenal conduit (10%of cases) if concerns about size
or inflow.
6. Living donor transplant:
a. Careful preoperative planning with ultrasound and
CT scans.
b. Management of the graft outflow is critical. Use
the ostia of the left and middle hepatic veins and
open diagonally onto the inferior vena cava.
c. Use microsurgical techniques for the arterial anas-
tomosis. This center collaborates with pediatric
plastic surgeons for the arterial anastomoses.
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d. Dissect the artery as far back as possible and help
the micro-surgeon set up the anastomosis.
e. One or two arteries with end-to-end anastomoses
using 8–0 interrupted nylon sutures.
f. Assure that there is no kink in the artery when the
retractor is released.
7. Liberally leave the abdomen open whenever concerns
that the fascial closure is too tight.
8. IV dipyridamole 30 mg and heparin 500 U in 50 mL D5
(<20 kg @ 5 mL/h, >20 kg @ 10 mL/h) with transition
to aspirin when patient taking full PO diet with 1 day
of overlap of these therapies.
9. While in the intensive care unit keep the central venous
pressure around 10 and keep the patient normoten-
sive.
10. Careful consideration regarding over transfusion—no
transfusions are given without specific permission of
the attending surgeon.
11. Ultrasound with Doppler assessment of the arterial
flow is completed on postoperative day 1 and there-
after if the liver function tests rise.
Step 3b: Best Practice Report: Biliary
Complications
Using the survey as a framework, we then asked a surgeon
from the highest performing center (lowest biliary compli-
cation rate) to give a talk on best practices, specifically fo-
cusing on the surgical technique. The program presented
the following as key components of their best practices:
1. Many biliary complications began at the donor opera-
tion: the senior attending surgeon does the donor oper-
ation when splitting of the liver is planned.
2. A segment II/III graft (deceased donor) gets the entire
celiac trunk, the main and left portal vein and the left
bile duct.
3. Liver flush with histidine-tryptophan-ketoglutarate
(HTK) solution.
4. All efforts are made to minimize both cold and warm
ischemia times.
5. Interrupted suture technique on the arterial
anastomosis—many biliary complications start
with inadequate arterial reconstruction.
6. Completion of the biliary-enteric anastomosis with in-
terrupted absorbable suture and over a stent.
7. No utilization of T-tubes.
8. Duct to duct biliary anastomosis using interrupted pro-
lene sutures with the knots tied on the outside.
Step 4: Plan to Disseminate Best Practices
A critical component of broad-based QI efforts involves
dissemination of best practices. Clearly as clinician con-
sidered changes to their practice, it is critical that the pur-
ported “best practices” come from a credible source. For-
tunately, SPLIT had established itself as such, with a track
record of efforts that have improved the care of pediatric
liver transplant patients. Based on the feedback from our
SPLIT annual meeting, attendees thought the SPLIT QI
symposiumwas valuable. Additional efforts will be needed
to disseminate these best practices. Our plan involves the
following:
1. Submission of the proceedings of the SPLIT QI sympo-
sium to the American Transplant Congress for presen-
tation.
2. Publication of the proceedings of the SPLIT QI sympo-
sium in a journal widely read by clinicians specializing
in transplantation.
3. Dissemination of the proceedings and best practices to
all active members of SPLIT.
4. Specifically requesting that nonsurgeon clinicians share
these proceedings with their surgical colleagues.
Step 5: Assessing the Effectiveness of the QI
Program
Data collection within SPLIT continues. We plan to con-
tinue to follow rates of hepatic artery thrombosis and biliary
complications within the collaborative group. We hope to
note a decrease in complication rates over the next several
years. We will continue to reinforce these best practices
at meetings and conference calls. We plan a repeat sur-
vey of current practices in approximately 1 year to assess
potential changes in practice.
Step 6: Future Targets for QI by SPLIT
Our group selected hepatic artery thrombosis and biliary
complications as our first targets for quality improvement
for several critical reasons. First of all, these are essen-
tially surgical complications and as a result identification
of cause-effect relationships is somewhat clearer. Second,
these practices seemed like good potential targets for en-
acting change. Thirdly, we noted broad variation in both
practices and outcomes, suggesting significant opportuni-
ties for improvement. Finally, therewas a clear appreciation
for the significant morbidity and potential mortality related
to both hepatic artery thrombosis and biliary complications.
As we move forward, our next QI targets will likely fulfill
similar characteristics. Current considerations include du-
ration of intubation following liver transplantation, length
of stay following transplantation in the hospital and in
the intensive care unit, incidence of severe postoperative
surgical infections and incidence of late biliary complica-
tions. Thereafter, we plan to target more complex outcome
such as nutrition status both pre-and posttransplant, re-
jection and immunosuppression management, long-term
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incidence of opportunistic infections, as well as functional
measures such as quality of life, frailty, functional status
and school performance.
Importantly, maintaining a robust database and program
like SPLIT has been a struggle, initially extramurally funded
but now funded by participating institutions. Pediatric liver
transplant programs clearly appreciate the utility of partici-
pation, but new approaches to fund such efforts are needed
to assure that high quality and clinically relevant data are
available to drive future important QI efforts. In addition,
more efforts to leverage existing data within transplanta-
tion are needed.
Using this Work as a Roadmap Forward
within Transplantation
Using the approach discussed herein, a broad based, mul-
tiinstitutional national quality improvement program within
transplantation seems attractive within the United States
or Canada. Certainly there are opportunities for improve-
ment, considering the broad variation in outcomes across
transplant centers within North America (1,25). The next
step is to focus on a high volume procedure (i.e. adult
liver transplantation) and a low volume procedure (i.e. mul-
tivisceral abdominal transplantation). Current data exists
on center-specific outcomes. Though the data are imper-
fect and fails to fully appreciate capture case complex-
ity, clinical experts can use it to identify high-performing
centers. These centers can present their processes (both
medical and surgical); experts can complete site visits to
high-performing centers. The focus on celebrating high-
performing centers and not using these data for center-
specific or regional centers is absolutely critical. Moreover,
collegiality must be maintained for a successful QI col-
laborative. This may sound naive within the competitive
nature of transplantation, but transplantation is no more
competitive the surgical marketplace in regions and States,
where effective physician driven QI collaboratives have im-
proved care of patients (3,5,7,8,26,27). National societies
such as the American Society of Transplantation and the
American Society of Transplant Surgeons are well suited
to lead these QI efforts, providing infrastructure, expertise
and most importantly mechanisms for dissemination of re-
sults. Clear best practices and improvement goals must
be established, and outcomes must be measured to deter-
mine success or failure of best practice initiatives. If initial
efforts are efficacious, the next step is expansion and part-
nership with payers. The previous work has clearly identi-
fied a valid financial case for effective quality improvement
(7,28–30).
Conclusion
SPLIT continues to provide a springboard for enhanced
quality initiatives for pediatric liver transplantation. While
data-driven observational quality improvement initiatives
can never replace the scientific rigor of the random-
ized controlled trial, they offer a practice-based, real-world
demonstration of how data can be leveraged to enhance
care and disseminate best practices. Similar approaches,
leveraging expertise across North American and using cur-
rently available data (such as OPTN data) offer significant
promise to improve care, in both low volume (multivisceral
transplantation) and high volume (deceased donor adult
liver transplantation), highly complex fields. Driven by clini-
cian experts, analysis of the best practices within the best-
performing centers has the potential to not only improve
but also accelerate how quality improvement initiatives can
benefit transplant patients on a broad scale.
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